Insulin resistance has long been recognized to be associated with hypertension, hyperinsulinemia and dyslipidemia. 1,2) These are also critical components of recently re-defined metabolic syndrome. [3][4][5] Insulin resistance and hyperinsulinemia have been demonstrated in not only genetic, but also nongenetic rat models of hypertension, such as the spontaneously hypertensive, 6) Dahl salt-sensitive, 7) Milan hypertensive, 8) and fructose-fed rat, 1,9) suggesting that mechanism leading to hypertension may be shared by these experimental models. Fructose-induced hypertension in rats represents an acquired model of insulin resistance such as metabolic syndrome (also known as syndrome X).10) Chronic fructose treatment in rats has been shown to elevate blood pressure in association with insulin resistance, hyperinsulinemia, and hypertriglyceridemia. Although the mechanisms underlying fructose-induced hypertension are not completely established, it has been proposed that increase in blood pressure in fructose-fed rats is secondary to the development of insulin resistance and hyperinsulinemia. 1,9) The flavonoids are a large group of plant-derived compounds that are known to exhibit a lot of biological effects including reducing plasma levels of low density lipoprotein, 11) scavenging reactive oxygen species, 12) inhibiting platelet aggregation, 13,14) and inhibiting carcinogenesis. 15) In addition, a number of flavonoids have been reported to dilate vascular smooth muscle and then reduce blood pressure in various animal models of hypertension. [16][17][18] Morin (3,5,7,2Ј,4Ј-pentahydroxyflavone; Fig. 1) is a kind of flavonoid found in the fig and other Moraceae, which are used as herbal medicines. 19,20) A very wide range of biological actions of morin including antioxidant properties, 21) inhibitory activity of oxidative modification of low density lipoprotein, 11) and vasorelaxant effect 22) has been reported. Such beneficial effects of morin could be expected to work in human or animal models of various diseases including metabolic syndrome, cardiovascular disease, and diabetes. However, there is little information about in vivo effects of morin in animal models or patients with above diseases. Therefore, in the present study, we examined the effects of chronic administration of morin on the blood pressure, renal function, and lipid metabolites in rats with HF-induced hypertension.
MATERIALS AND METHODS
Experimental DesignThe animal procedures were in strict accordance with the National Institutes of Healthy Guidelines for the Care and Use of laboratory Animals and were approved by the Institutional Animal Care and Utilization Committee. Male Sprague-Dawley rats (200-220 g) were purchased from Korean Experimental Animals Co. (Daejeon, Korea). The rats were housed in metabolic cages to collect 24-h urine samples in the animal room with an automatic temperature (22°C) and lighting (12 h light-dark cycle) control. An adaptation period of 1 week for vehicle (tap water) administration and blood pressure measurements wa...